Alignment Healthcare CEO John Kao Sells $7.1 Million in Stock

Alignment Healthcare CEO and Director John E. Kao sold approximately $7.12 million of company stock across two transactions on September 10 and September 11, 2026. These sales, totaling 557,870 shares, occurred as the company faces a recent analyst downgrade and downward pressure on its share price.

"While the company has shown consistent execution in challenging environments, the trajectory of future earnings remains uncertain," said John Ransom, an analyst at Raymond James, in a recent note.

Breakdown of Insider Transactions

The share sales were executed through two mechanisms, with the larger portion tied to mandatory tax requirements:

• September 10 Sale: 172,600 shares were sold pursuant to a Rule 10b5-1 trading plan that Kao adopted on May 27, 2026. These plans allow corporate insiders to set up a predetermined schedule for selling stock to avoid concerns regarding insider trading.
• September 11 Sale: 385,270 shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. This trade was non-discretionary, as it was triggered by the tax event rather than a voluntary decision to liquidate holdings.

Market Context and Analyst Outlook

The insider activity follows a downward revision by Raymond James, which downgraded Alignment Healthcare (ALHC) from "Strong Buy" to "Outperform." The firm also lowered its price target for the stock from $22 to $19, citing concerns regarding earnings visibility as the company pursues geographic expansion beyond its core California market.

As of September 15, 2026, Alignment Healthcare stock was trading at $10.13, marking a 21.7% decline from the previous close. This volatility reflects market reactions to the company's growth strategy and the uncertainty surrounding its profit trajectory in new territories.